Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals.
Dudek
Dariusz
D
Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland. mcdudek@cyf-kr.edu.pl
Zmudka
Krzysztof
K
Kaluza
Grzegorz L
GL
Kuta
Marcin
M
Pieniazek
Piotr
P
Przewlocki
Tadeusz
T
Zorkun
Cafer
C
Legutko
Jacek
J
Gajos
Grzegorz
G
Bartuś
Stanislaw
S
Bryniarski
Leszek
L
Dziewierz
Artur
A
Pasowicz
Mieczyslaw
M
Dubiel
Jacek S
JS
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006764:Hospitals, Community; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D010360:Patient Transfer; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D006493:Heparin; D010959:Tissue Plasminogen Activator; D000077284:Abciximab